trial · primary record
Bevacizumab
Advanced Lung Non-Squamous Non-Small Cell Carcinoma
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 300 |
| Primary completion | 2029-06-30 |
| Primary endpoint | Progression-free survival (PFS) |
| Registry ID | NCT04181060 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:33:07.430Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04181060
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.